P/E ratio for Humana (HUM)
P/E ratio as of March 2023 (TTM): 22.9
According to Humana's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.8786. At the end of 2021 the company had a P/E ratio of 20.4.
P/E ratio history for Humana from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 20.4 | 26.31% |
| 2020 | 16.1 | -11.32% |
| 2019 | 18.2 | -22.36% |
| 2018 | 23.4 | 58.41% |
| 2017 | 14.8 | -71.18% |
| 2016 | 51.3 | 144.96% |
| 2015 | 20.9 | 8.11% |
| 2014 | 19.4 | 45.9% |
| 2013 | 13.3 | 46.15% |
| 2012 | 9.08 | -11.2% |
| 2011 | 10.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Centene CNC | 18.6 | -18.91% | 🇺🇸 USA |
 Cigna CI | 11.6 | -49.30% | 🇺🇸 USA |
 UnitedHealth UNH | 23.3 | 1.72% | 🇺🇸 USA |
 Molina Healthcare
MOH | 18.6 | -18.81% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.